AAA517
/ Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 20, 2021
Ministry of Food and Drug Safety approves 9 clinical trials including COVID-19 vaccine [Google translation]
(Health Korea News)
- "Novartis Korea is conducting phase 3 clinical trials of 'AAA517' (PSMA-11 trifluoroacetate) and 'AAA617' at Seoul National University Hospital and Asan Medical Center. This is a study comparing '177Lu-PSMA-617' and standard therapy in combination with standard therapy alone in 30 adult male patients with metastatic hormone-sensitive prostate cancer (mHSPC)."
New P3 trial • Genito-urinary Cancer • Oncology • Prostate Cancer
1 to 1
Of
1
Go to page
1